Spyre Therapeutics, Inc. (SYRE) analyst actions
Rating and price-target actions on SYRE in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the SYRE overview →
1 measured SYRE analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Spyre Therapeutics Announces Launch of SPY772 Program and Initiation of Phase 2 SKYLIGHT Trial in Hidradenitis Suppurativa | Press release | +0.74% | — |
Keep exploring
More SYRE: earnings → · SEC filings → · SYRE overview →